Sign in

NCT05038553Active, not recruiting

Chronic Pain in Rheumatoid Arthritis

CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition

Source: ClinicalTrials.gov · Last updated 28 May 2026

Brief summary (registry, in English)

The objective is to identify modifiable clinical factors and neurobiological pathways that lead to the development of chronic pain in patients with early rheumatoid arthritis. Participants will undergo quantitative sensory testing, a type of testing that involves assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to assess neuroimaging markers that have previously been shown to be involved in chronic pain.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
125 (estimated)
First submitted
30 Aug 2021
Start date
12 Oct 2021
Primary completion date
28 Feb 2027
Lead sponsor
Northwestern University
NCT number
NCT05038553

What you commit to

  • Study type: Observational
  • Planned participants: 125
  • From 12 Oct 2021 to the primary completion date, 28 Feb 2027
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Peripheral vascular disease

Age

  • Age ≤ 80 years old

Other

  • Routine, scheduled opioid use
  • Routine, scheduled prednisone dose \>10 mg or its equivalent
  • Peripheral neuropathy
  • Raynaud's phenomenon requiring treatment, manifested by claudication or ischemic rest pain
  • Uncontrolled blood pressure
    • Additional Inclusion Criteria for neuroimaging:
  • Right-handed or ambidextrous
  • Ability to lie on their back for the duration of the MRI scans
    • Additional Exclusion Criteria for neuroimaging:
  • Severe claustrophobia precluding MRI
  • Unable to fit comfortably in the MRI scanner (usually only occurs if body mass index \>40 kg/m2)
  • Pregnant
  • Contraindications to MRI

Who the study is looking for

  • Age ≥18 years
  • Meet either the 1987 or 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria for RA
  • Persistent joint symptoms ≤ 2 years
  • Active inflammatory disease
  • If taking opioids on an as needed (prn) basis, must be able to hold opioid for 12 hours before study procedures
  • If taking NSAIDs, must be able to hold NSAIDS for 24 hours before study procedures
  • If taking a central-acting pain medication, must be on a stable dose and able to stay on a stable dose throughout study

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status
Johns Hopkins University
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Northwestern University
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status
University of Colorado
Coordinator of this site? Confirm its status
DenverUnited StatesUnknown status
Hospital for Special Surgery
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.